Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Running trials

• Recruiting

  A Study of Ropeg-Interferon in People With Polycythemia Vera

  NCT07886801· Phase 2· Source

• Recruiting

  Researching the Effect of Exercise on Cancer

  NCT04589468· Source

• Recruiting

  A Study of Romosozumab in People With Breast Cancer and Osteoporosis

  NCT07776613· Phase 2· Source

• Recruiting

  A Study of Luspatercept in People With Anemia

  NCT07725497· Phase 2· Source

• Recruiting

  A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

  NCT05751434· Phase 2· Source

• Recruiting

  A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer

  NCT07631000· Phase 2· Source

• Recruiting

  A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma

  NCT07454382· Phase 2· Source

• Active, not recruiting

  A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer

  NCT07335796· Phase 2· Source

• Recruiting

  A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

  NCT07323732· Phase 2· Source

• Recruiting

  A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

  NCT07227636· Phase 2· Source

• Recruiting

  A Dietary Study for People With Multiple Myeloma

  NCT07226609· Source

• Recruiting

  A Study of 177Lu-PSMA-617 in People With Gliomas

  NCT07223034· Phase 1· Source

• Recruiting

  A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

  NCT07105059· Phase 1· Source

• Recruiting

  A Study of Tarlatamab for People With Prostate Cancer

  NCT07111507· Phase 2· Source

• Recruiting

  A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma

  NCT07099391· Phase 1/2· Source

• Recruiting

  A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

  NCT06984861· Phase 2· Source

• Recruiting

  Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

  NCT06934889· Phase 1· Source

• Recruiting

  A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

  NCT06835972· Phase 1/2· Source

• Recruiting

  A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer

  NCT06807632· Phase 1· Source

• Recruiting

  A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma

  NCT06765317· Phase 2· Source

• Recruiting

  A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

  NCT06773195· Phase 1/2· Source

• Recruiting

  A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma

  NCT06736613· Phase 2· Source

• Recruiting

  A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant

  NCT06679829· Phase 2· Source

• Recruiting

  A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer or Malignant Peritoneal Mesothelioma

  NCT06623396· Phase 1· Source

• Recruiting

  A Study of Sotorasib in People With Non-Small Cell Lung Cancer

  NCT06582771· Phase 2· Source

• Recruiting

  A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

  NCT06563479· Phase 3· Source

• Recruiting

  A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

  NCT06457919· Phase 1/2· Source

• Recruiting

  A Registry for People With Lung Cancer

  NCT06424327· Source

• Recruiting

  A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

  NCT06394804· Phase 2· Source

• Recruiting

  A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

  NCT06312124· Source

• Active, not recruiting

  A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

  NCT06251973· Phase 2· Source

• Recruiting

  A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

  NCT06123338· Phase 2· Source

• Active, not recruiting

  A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy

  NCT06240598· Phase 2· Source

• Active, not recruiting

  A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

  NCT06110793· Phase 1/2· Source

• Recruiting

  A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer

  NCT06130280· Phase 2· Source

• Recruiting

  A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

  NCT06099769· Phase 2· Source

• Recruiting

  A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)

  NCT06083922· Phase 2· Source

• Recruiting

  A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy

  NCT06066346· Phase 2· Source

• Recruiting

  A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

  NCT06057935· Phase 2· Source

• Recruiting

  A Study of Avutometinib and Defactinib in People With Thyroid Cancer

  NCT06007924· Phase 2· Source

• Recruiting

  A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

  NCT05837767· Source

• Active, not recruiting

  A Study of IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma

  NCT05912244· Phase 2· Source

• Active, not recruiting

  A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

  NCT05868265· Phase 2· Source

• Recruiting

  A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer

  NCT05910294· Source

• Recruiting

  A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

  NCT05859074· Phase 1· Source

• Active, not recruiting

  A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)

  NCT05814549· Source

• Active, not recruiting

  A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

  NCT05775094· Phase 1· Source

• Recruiting

  A Study of Tucatinib and Trastuzumab in People With Rectal Cancer

  NCT05672524· Phase 2· Source

• Active, not recruiting

  Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

  NCT05642962· Phase 1/2· Source

• Active, not recruiting

  A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment

  NCT05556798· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer8 recruiting
• Multiple myeloma7 recruiting
• Head and neck cancer6 recruiting
• Metastatic breast cancer5 recruiting
• Colorectal cancer4 recruiting
• Ovarian cancer4 recruiting
• Sarcoma4 recruiting
• Childhood cancers3 recruiting
• Prostate cancer3 recruiting
• Bladder cancer2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Gastric and esophageal cancer2 recruiting
• Glioblastoma2 recruiting
• Kidney cancer2 recruiting
• Melanoma2 recruiting
• Mesothelioma2 recruiting
• Myeloproliferative neoplasms2 recruiting
• Chronic kidney disease1 recruiting
• Endometrial cancer1 recruiting
• Liver and biliary tract cancer1 recruiting
• Osteoporosis1 recruiting
• Pancreatic cancer1 recruiting
• Thyroid cancer1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

  NCT07414992· Phase 2· Source

• Withdrawn

  A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer

  NCT07428044· Phase 2· Source

• Completed

  A Study Comparing Geriatric Co-Management With Geriatric Guided Supportive Care in Older Patients Receiving Chemoradiation Therapy for Their Head and Neck Cancer

  NCT05239000· Source

• Completed

  A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones

  NCT05133440· Phase 2· Source

• Completed

  A Study of Pembrolizumab and Cryoablation in People With Mesothelioma

  NCT05071014· Phase 1· Source

• Completed

  Exercise Therapy in Cancer Patients Who Are Recovering From COVID-19

  NCT04824443· Phase 1· Source

• Completed

  Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer

  NCT04457284· Phase 2· Source

• Completed

  ZW25 in Women With Endometrial Cancers

  NCT04513665· Phase 2· Source

• Completed

  Proton Craniospinal Radiation Therapy vs. Partial Photon Radiation Therapy for Leptomeningeal Metastasis From Solid Tumors

  NCT04343573· Phase 2· Source

• Completed

  Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

  NCT04337970· Phase 1/2· Source

• Completed

  Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma

  NCT04068831· Phase 2· Source

• Terminated

  A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer

  NCT04019327· Phase 1/2· Source

• Completed

  A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer

  NCT03093922· Phase 2· Source

• Completed

  Trial of Ado-Trastuzumab Emtansine for Patients With HER2 Amplified or Mutant Cancers

  NCT02675829· Phase 2· Source